MJBizDaily reports that a federal move against hemp could imperil seed banks and the genetic diversity they hold. For breeders, distributors and research collections the risks run from restricted movement of material to the loss of rare cultivars. This piece separates the reporting from the likely practical impacts and sets out the questions professionals should be tracking next.

Nebraska’s newly authorised medical cannabis operators are reportedly prepared to begin cultivation but remain without seed shipments, according to the Omaha World-Herald. For growers, regulators and service providers the gap between licensing and plant material arrival raises practical operational and compliance questions. This piece explains the immediate implications for the industry and what professionals should monitor next.

Omaha World-Herald reports that Nebraska cultivators approved under the state medical cannabis rollout still lack seed stock as they near planting. This technical explainer outlines the practical options, compliance considerations and genetic-supply risks that licensed operators should weigh when a programme reaches the planting phase but genetics have not arrived.